PR Newswire - China's Personalized mRNA Cancer Therapy Sector Ac...
BEIJING, Aug. 21, 2026 /PRNewswire/ -- Personalized mRNA cancer therapy has recently reached an important milestone. An international Phase 3 study in high-risk melanoma reported positive results, fur...
Read More


ภาษาไทย
English